Meta-Analysis of Complete Remission Rates Following First-Line Salvage Treatment after Anti-CD19 CAR-T Failure in Adult Patients with Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia

被引：0
|
作者：
Tomasik, Jaromir [1 ]
Bilicki, Dominik [1 ]
Basak, Grzegorz [1 ]
机构：
[1] Med Univ Warsaw, Dept Hematol Transplantat & Internal Med, Warsaw, Poland
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-204502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1421 / 1422
页数：2
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF RELMACABTAGENE AUTOLEUCEL (ANTI-CD19 AUTOLOGOUS CAR-T CELL IMMUNOTHERAPY PRODUCT) VS SALVAGE CHEMOTHERAPY FOR CHINESE RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA PATIENTS
    Lin, Z.
    Zuo, C.
    Jiang, Y.
    Su, W.
    Yao, X.
    Man, Y.
    Wu, Q.
    Guo, Z.
    Su, F.
    Xuan, J.
    VALUE IN HEALTH, 2022, 25 (12) : S62 - S63
  • [42] BRIDGING THERAPY PRIOR TO TREATMENT WITH ANTI-CD19 CAR T CELLS FOR RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AND YOUNG ADULTS - A MULTINATIONAL RETROSPECTIVE ANALYSIS
    Breidenbach, Maike
    Bader, Peter
    Attarbaschi, Andishe
    Rossig, Claudia
    Meisel, Roland
    Metzler, Markus
    Subklewe, Marion
    Mueller, Fabian
    Schlegel, Paul-Gerhard
    Von Luettichau, Irene Teichert
    Bourquin, Jean-Pierre
    Escherich, Gabriele
    Cario, Gunnar
    Lang, Peter
    Krauss, Ramona
    von Stackelberg, Arend
    Willier, Semjon
    Peters, Christina
    Feuchtinger, Tobias
    BONE MARROW TRANSPLANTATION, 2024, 59 : 198 - 199
  • [43] CD19-negative relapse in adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia following treatment with blinatumomab-a post hoc analysis
    Horst, Heinz-August
    Zugmaier, Gerhard
    Martinelli, Giovanni
    Mergen, Noemi
    Velasco, Kelly
    Zaman, Faraz
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : E222 - E225
  • [44] The role of allogeneic haematopoietic cell transplantation as consolidation after anti-CD19 CAR-T cell therapy in adults with relapsed/refractory acute lymphoblastic leukaemia: a prospective cohort study
    Han, Shi
    Zhou, Lijuan
    Chen, Youyou
    Zhou, Xuan
    Guo, Zhenling
    Yang, Jilong
    Jin, Bo
    Liu, Yuchen
    Chang, Lung-Ji
    Li, Yuhua
    Tu, Sanfang
    BONE MARROW TRANSPLANTATION, 2022, 57 (03) : 513 - 516
  • [45] Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trial
    Luo, Yi
    Gao, Lei
    Liu, Jia
    Yang, Luxin
    Wang, Lu
    Lai, Xiaoyu
    Gao, Shichun
    Liu, Lizhen
    Zhao, Lu
    Ye, Yishan
    Wang, Manning
    Shen, Lianjun
    Cao, W. William
    Wang, Dongrui
    Li, Wenling
    Zhang, Xi
    Huang, He
    ECLINICALMEDICINE, 2024, 67
  • [46] The role of allogeneic haematopoietic cell transplantation as consolidation after anti-CD19 CAR-T cell therapy in adults with relapsed/refractory acute lymphoblastic leukaemia: a prospective cohort study
    Shi Han
    Lijuan Zhou
    Youyou Chen
    Xuan Zhou
    Zhenling Guo
    Jilong Yang
    Bo Jin
    Yuchen Liu
    Lung-Ji Chang
    Yuhua Li
    Sanfang Tu
    Bone Marrow Transplantation, 2022, 57 : 513 - 516
  • [47] Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis
    Elsallab, Magdi
    Ellithi, Moataz
    Hempel, Susanne
    Abdel-Azim, Hisham
    Abou-el-Enein, Mohamed
    CANCER GENE THERAPY, 2023, 30 (06) : 845 - 854
  • [48] Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis
    Magdi Elsallab
    Moataz Ellithi
    Susanne Hempel
    Hisham Abdel-Azim
    Mohamed Abou-el-Enein
    Cancer Gene Therapy, 2023, 30 : 845 - 854
  • [49] Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients
    Michael Maschan
    Paolo F. Caimi
    Jane Reese-Koc
    Gabriela Pacheco Sanchez
    Ashish A. Sharma
    Olga Molostova
    Larisa Shelikhova
    Dmitriy Pershin
    Alexey Stepanov
    Yakov Muzalevskii
    Vinicius G. Suzart
    Folashade Otegbeye
    David Wald
    Ying Xiong
    Darong Wu
    Adam Knight
    Ibe Oparaocha
    Beatrix Ferencz
    Andre Roy
    Andrew Worden
    Winfried Kruger
    Michael Kadan
    Dina Schneider
    Rimas Orentas
    Rafick-Pierre Sekaly
    Marcos de Lima
    Boro Dropulić
    Nature Communications, 12
  • [50] Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients
    Maschan, Michael
    Caimi, Paolo F.
    Reese-Koc, Jane
    Sanchez, Gabriela Pacheco
    Sharma, Ashish A.
    Molostova, Olga
    Shelikhova, Larisa
    Pershin, Dmitriy
    Stepanov, Alexey
    Muzalevskii, Yakov
    Suzart, Vinicius G.
    Otegbeye, Folashade
    Wald, David
    Xiong, Ying
    Wu, Darong
    Knight, Adam
    Oparaocha, Ibe
    Ferencz, Beatrix
    Roy, Andre
    Worden, Andrew
    Kruger, Winfried
    Kadan, Michael
    Schneider, Dina
    Orentas, Rimas
    Sekaly, Rafick-Pierre
    de Lima, Marcos
    Dropulic, Boro
    NATURE COMMUNICATIONS, 2021, 12 (01)
12345